Comparative Efficacy of Yohimbine Against Pyridostigmine for the Treatment of Orthostatic Hypotension in Autonomic Failure
- 1 November 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 56 (5), 847-851
- https://doi.org/10.1161/hypertensionaha.110.154898
Abstract
Orthostatic hypotension affects patients with autonomic failure producing considerable disability because of presyncopal symptoms. Severely affected patients may have residual sympathetic tone that can be engaged to increase blood pressure (BP) with the α-2 adrenergic antagonist yohimbine. This medication activates sympathetic outflow centrally and unrestrains norepinephrine release from noradrenergic neurons. Alternatively, the acetylcholinesterase inhibitor, pyridostigmine, can increase sympathetic tone by improving ganglionic cholinergic neurotransmission. Our purpose was to compare these complementary approaches and to explore whether the combination would lead to synergistic increases in BP. We compared the effects of 60 mg of pyridostigmine and 5.4 mg of yohimbine in a single-blind, randomized, placebo-controlled, crossover fashion. In a subset of patients we tested the combination of pyridostigmine and yohimbine. Our primary outcome was the change in standing diastolic BP 60 minutes after drug administration from baseline. We studied a total of 31 patients with severe autonomic failure. Yohimbine significantly improved standing diastolic BP as compared with placebo (11±3 mm Hg [95% CI: 6 to 16 mm Hg]; PP=0.823). Only yohimbine showed a significant improvement in presyncopal symptoms. Sixteen patients received the combination of pyridostigmine and yohimbine, but no evidence of synergistic pressor effect was found. Engaging residual sympathetic tone with yohimbine is a more effective approach to improve orthostatic hypotension as compared with pyridostigmine in patients with severe orthostatic hypotension.Keywords
This publication has 21 references indexed in Scilit:
- 9-Alpha-fluorohydrocortisone in the Treatment of Postural HypotensionActa Medica Scandinavica, 2009
- Neuropharmacologic Distinction of Neurogenic Orthostatic Hypotension SyndromesClinical Neuropharmacology, 2006
- Management of Hypertension in the Setting of Autonomic FailureHypertension, 2005
- Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotensionJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Treatment of Orthostatic HypotensionSeminars in Neurology, 2003
- N N -Nicotinic Blockade as an Acute Human Model of Autonomic FailureHypertension, 1998
- Isolated Failure of Autonomic Noradrenergic NeurotransmissionNew England Journal of Medicine, 1986
- Evidence for the existence of vascular alpha 2-adrenergic receptors in humans.Hypertension, 1984
- Mineralocorticoid-Induced Hypertension in Patients with Orthostatic HypotensionNew England Journal of Medicine, 1979
- Orthostatic hypotension. Treatment with sodium chloride and sodium retaining steroid hormonesArchives of Internal Medicine, 1968